Targeting autophagy in cancer

JMM Levy, CG Towers, A Thorburn - Nature Reviews Cancer, 2017 - nature.com
Autophagy is a mechanism by which cellular material is delivered to lysosomes for
degradation, leading to the basal turnover of cell components and providing energy and …

Therapeutic advances of targeting receptor tyrosine kinases in cancer

C Tomuleasa, AB Tigu, R Munteanu… - … and Targeted Therapy, 2024 - nature.com
Receptor tyrosine kinases (RTKs), a category of transmembrane receptors, have gained
significant clinical attention in oncology due to their central role in cancer pathogenesis …

[HTML][HTML] Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents

C Verbaanderd, H Maes, MB Schaaf… - …, 2017 - ncbi.nlm.nih.gov
Chloroquine (CQ) and hydroxychloroquine (HCQ) are well-known 4-aminoquinoline
antimalarial agents. Scientific evidence also supports the use of CQ and HCQ in the …

A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms

M Cojoc, K Mäbert, MH Muders, A Dubrovska - Seminars in cancer biology, 2015 - Elsevier
Similar to normal tissue, many tumors have a hierarchical organization where tumorigenic
cancer stem cells (CSCs) differentiate into non-tumorigenic progenies. A host of studies …

ALK in neuroblastoma: biological and therapeutic implications

RM Trigg, SD Turner - Cancers, 2018 - mdpi.com
Neuroblastoma (NB) is the most common and deadly solid tumour in children. Despite the
development of new treatment options for high-risk NB, over half of patients relapse and five …

[HTML][HTML] The role of autophagy in resistance to targeted therapies

L Mele, V Del Vecchio, D Liccardo, C Prisco… - Cancer Treatment …, 2020 - Elsevier
Autophagy is a self-degradative cellular process, involved in stress response such as
starvation, hypoxia, and oxidative stress. This mechanism balances macro-molecule …

Pro-survival autophagy and cancer cell resistance to therapy

CK Das, M Mandal, D Kögel - Cancer and Metastasis Reviews, 2018 - Springer
Resistance to therapy is one of the prime causes for treatment failure in cancer and recurrent
disease. In recent years, autophagy has emerged as an important cell survival mechanism …

Molecular histology of lung cancer: from targets to treatments

SL Wood, M Pernemalm, PA Crosbie… - Cancer treatment …, 2015 - Elsevier
Lung cancer is the leading cause of cancer-related death worldwide with a 5-year survival
rate of less than 15%, despite significant advances in both diagnostic and therapeutic …

ALK: a tyrosine kinase target for cancer therapy

VR Holla, YY Elamin, AM Bailey… - Molecular …, 2017 - molecularcasestudies.cshlp.org
The anaplastic lymphoma kinase (ALK) gene plays an important physiologic role in the
development of the brain and can be oncogenically altered in several malignancies …

Current molecular-targeted therapies in NSCLC and their mechanism of resistance

Z Schrank, G Chhabra, L Lin, T Iderzorig, C Osude… - Cancers, 2018 - mdpi.com
Lung cancer is treated with many conventional therapies, such as surgery, radiation, and
chemotherapy. However, these therapies have multiple undesirable side effects. To bypass …